New Treatment for Concussion with Dr. Bansal

Dr. Vishal Bansal, MD. FACS is the director of trauma surgery at Scripps Mercy Hospital in San Diego and chief scientific officer of Oxeia BioPharmaceuticals. As a trauma surgeon, Dr. Bansal operates on patients who are victims of a range of blunt force or penetrating traumas, from car crashes to gunshot wounds to stabbings to brain injuries. Dr. Bansal has seen dramatic advances in many areas of medicine, but laments that treatment for concussions is still primitive and focuses on the symptoms rather than a cure. Dr. Bansal is a physician with a dream: He wants to develop the first FDA-approved therapeutics that treat not only the immediate symptoms of a concussion, but also the underlying damage. The company co-founded by Dr. Bansal, Oxeia Biopharmaceuticals, has a therapeutic, OXE-103 that has been approved by the FDA for Phase 2 testing. Dr. Bansal will talk about the company’s upcoming trials and the promise of their drug for those suffering from the long-term effects of concussions. Says, Dr. Bansal, “Rest is not enough.”